Goldman Sachs’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $50.3K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $127K | Buy |
|
|||||
|
2024
Q1 | $64.2K | Buy |
|
|||||
|
2023
Q4 | $56.6K | Sell |
|
|||||
|
2023
Q3 | $336K | Sell |
|
|||||
|
2023
Q2 | $959K | Sell |
|
|||||
|
2023
Q1 | $3.05M | Buy |
|
|||||
|
2022
Q4 | $1.15M | Sell |
|
|||||
|
2022
Q3 | $1.11M | Buy |
|
|||||
|
2022
Q2 | $959K | Buy |
|
|||||
|
2022
Q1 | $1.44M | Buy |
|
|||||
|
2021
Q4 | $1.01M | Buy |
|
|||||
|
2021
Q3 | $1.09M | Sell |
|
|||||
|
2021
Q2 | $5.16M | Buy |
|
|||||
|
2021
Q1 | $5.46M | Sell |
|
|||||
|
2020
Q4 | $10.4M | Buy |
|
|||||
|
2020
Q3 | $5.53M | Buy |
|
|||||
|
2020
Q2 | $5.3M | Buy |
|
|||||
|
2020
Q1 | $1.12M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $98K | Sell |
|
|||||
|
2018
Q1 | $285K | Buy |
|